SKYT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient trader. SKYT is trading at $31.73 with the deal value anchored around $35, leaving roughly ~10% upside that likely takes until Q2–Q3 2026 to realize and is capped by the merger consideration. With no Intellectia buy signals today and the stock already priced as a merger-arb, the risk/reward is not attractive for a fast-move entry.
Trend/structure: Short-term trend is still broadly constructive on moving averages (SMA_5 > SMA_20 > SMA_200), but momentum is weakening. MACD histogram is negative (-0.324) and expanding lower, signaling deteriorating momentum after the recent run-up. RSI(6)=46.44 is neutral, consistent with consolidation rather than a fresh upside impulse. Key levels: Pivot 33.03 is now overhead resistance; immediate support is S1 30.56 (a break below increases odds of a slide toward S2 29.03). Upside levels to watch are 35.50 (R1, close to deal price) and 37.03 (R2, likely hard to sustain given acquisition cap). Near-term bias: sideways-to-down until momentum stabilizes.
Intellectia Proprietary Trading Signals
IonQ acquisition agreement at $35/share sets a clear reference value and can support the stock on dips (merger-arb floor/anchor).
Deal rationale is strategic (IonQ wants manufacturing/supply chain control), which can improve perceived close probability.
Options sentiment is call-heavy (low put/call ratios), implying the market is leaning toward deal completion.
Prior operating momentum: 2025/Q3 showed strong reported growth in revenue and margins, supporting fundamental narrative even if largely superseded by the deal.
Upside is capped: with the transaction price around $35, the remaining spread from $31.73 is modest and may take multiple quarters (expected close Q2–Q3 2026).
Deal risk/uncertainty: timing, regulatory/process risk, and potential customer/strategic objections can widen the spread.
Headline/legal overhang: law firm investigations (fiduciary duty-related) can add noise and short-term pressure.
Technical momentum is weakening (negative, expanding MACD histogram), increasing the chance of a drift toward support ($30.56 / $29.
before any move back toward $35.
Latest reported quarter: 2025/Q3. Revenue rose to $150.741M (+60.68% YoY) and gross margin improved to 24.03% (+11.40% YoY), indicating solid top-line growth and better profitability. Net income (+9424.67% YoY) and EPS (+9733.33% YoY) surged to $144.013M and $2.95, respectively—figures that look unusually large and may reflect one-time items, mix shifts, or non-recurring benefits rather than steady-state earnings power. Next scheduled earnings: QDEC 2025 on 2026-02-25 (after hours), but market focus will likely remain deal progress rather than standalone quarter-to-quarter performance.
Recent trend: Clear shift from Buy/Overweight to Hold/Neutral after the IonQ acquisition announcement.
